ATE325805T1 - Herstellung von kristalliner dihydratform von azithromycin - Google Patents

Herstellung von kristalliner dihydratform von azithromycin

Info

Publication number
ATE325805T1
ATE325805T1 AT01204550T AT01204550T ATE325805T1 AT E325805 T1 ATE325805 T1 AT E325805T1 AT 01204550 T AT01204550 T AT 01204550T AT 01204550 T AT01204550 T AT 01204550T AT E325805 T1 ATE325805 T1 AT E325805T1
Authority
AT
Austria
Prior art keywords
preparation
azithromycin
dihydrate form
crystalline dihydrate
crystalline
Prior art date
Application number
AT01204550T
Other languages
English (en)
Inventor
Jasanada Miguel Santos Bayod
Garcia Isidro Llorente
Mari Felix Fernandez
Original Assignee
Astur Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astur Pharma Sa filed Critical Astur Pharma Sa
Application granted granted Critical
Publication of ATE325805T1 publication Critical patent/ATE325805T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT01204550T 1999-11-26 2000-02-23 Herstellung von kristalliner dihydratform von azithromycin ATE325805T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES009902620A ES2177373B1 (es) 1999-11-26 1999-11-26 Preparacion de azitromicina en su forma no cristalina

Publications (1)

Publication Number Publication Date
ATE325805T1 true ATE325805T1 (de) 2006-06-15

Family

ID=8310747

Family Applications (2)

Application Number Title Priority Date Filing Date
AT01204550T ATE325805T1 (de) 1999-11-26 2000-02-23 Herstellung von kristalliner dihydratform von azithromycin
AT00500028T ATE243704T1 (de) 1999-11-26 2000-02-23 Herstellung von nicht-kristallinen und kristallinen dihydratformen von azithromycin

Family Applications After (1)

Application Number Title Priority Date Filing Date
AT00500028T ATE243704T1 (de) 1999-11-26 2000-02-23 Herstellung von nicht-kristallinen und kristallinen dihydratformen von azithromycin

Country Status (9)

Country Link
US (1) US6451990B1 (de)
EP (2) EP1103558B1 (de)
JP (2) JP4260354B2 (de)
AT (2) ATE325805T1 (de)
CA (1) CA2326930C (de)
DE (2) DE60003509T2 (de)
ES (2) ES2177373B1 (de)
PL (1) PL195910B1 (de)
TR (1) TR200003474A3 (de)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HRP20020231A2 (en) * 2002-03-18 2003-12-31 Pliva D D ISOSTRUCTURAL PSEUDOPOLYMORPHS OF 9-DEOXO-9a-AZA-9a-METHYL-9a-HOMOERYTHROMYCIN A
CA2245398C (en) 1998-08-21 2002-01-29 Apotex Inc. Azithromycin monohydrate isopropanol clathrate and methods for the manufacture thereof
ES2162764B1 (es) * 2000-05-17 2003-04-01 Ercros Ind Sa Forma polimorfica del dihidrato de azitromicina, y su procedimiento deobtencion.
CA2429639C (en) * 2000-11-27 2009-07-14 Biochemie S.A. Stable azithromycin monohydrate
IN190080B (de) * 2001-01-29 2003-06-07 Alembic Ltd
KR100491183B1 (ko) * 2001-03-21 2005-05-25 한미약품 주식회사 아지트로마이신의 제조방법 및 이 방법에 사용되는9-데옥소-9에이-아자-9에이-호모에리트로마이신 에이의결정성 수화물
EP1671979B1 (de) * 2001-05-22 2008-08-13 Pfizer Products Inc. Neue Kristallforme von Azithromycin
IL158591A0 (en) * 2001-05-22 2004-05-12 Pfizer Prod Inc Crystal forms of azithromycin
US6861413B2 (en) 2001-05-22 2005-03-01 Pfizer Inc. Stable non-dihydrate azithromycin oral suspensions
IL161996A0 (en) 2001-12-21 2005-11-20 Pfizer Prod Inc Directly compressible formulations of azithromycin
US7452692B2 (en) 2002-02-13 2008-11-18 Teva Gyógyszergyár Zártkörüen Müködö Részvénytársaság Method for extracting a macrolide from biomatter
JP4261365B2 (ja) 2002-02-13 2009-04-30 テバ ジョジセルジャール ザ−トケルエン ムケド レ−スベニュタ−ルシャシャ−グ 生物学的物質からのマクロライドの抽出方法
HRP20020614A2 (en) 2002-07-22 2004-06-30 PLIVA-ISTRAŽIVAČKI INSTITUT d.o.o. Rhombic pseudopolymorph of 9-deoxo-9a-aza-9a-methyl-9a-homoerythromycin a
WO2004089958A2 (en) * 2003-03-31 2004-10-21 TEVA Gyógyszergyár Részvénytársaság Crystallization and purification of macrolides
ATE378345T1 (de) 2003-07-24 2007-11-15 Teva Gyogyszergyar Zartkoeruee Verfahren zur aufreinigung von makroliden
JP2007513145A (ja) * 2003-12-04 2007-05-24 ファイザー・プロダクツ・インク 医薬用多微粒子の製造方法
US7384921B2 (en) * 2004-02-20 2008-06-10 Enanta Pharmaceuticals, Inc. Polymorphic forms of 6-11 bicyclic ketolide derivatives
US7468428B2 (en) 2004-03-17 2008-12-23 App Pharmaceuticals, Llc Lyophilized azithromycin formulation
US20060116336A1 (en) * 2004-03-17 2006-06-01 American Pharmaceutical Partners, Inc. Lyophilized azithromycin formulation
WO2006115494A1 (en) * 2005-04-26 2006-11-02 American Pharmaceutical Partners, Inc. Lyophilized azithromycin formulation
US7683162B2 (en) 2004-08-30 2010-03-23 Taro Pharmaceutical Industries Limited Process of preparing a crystalline azithromycin monohydrate
US7582312B2 (en) * 2004-11-15 2009-09-01 Discovery Laboratories, Inc. Methods to produce lung surfactant formulations via lyophilization and formulations and uses thereof
US7464012B2 (en) * 2004-12-10 2008-12-09 L'air Liquide, Societe Anonyme A Directoire Et Conseil De Surveillance Pour L'etude Et L'exploitation Des Procedes Georges Claude Simplified process simulator
CA2584358A1 (en) 2004-12-01 2006-06-08 Teva Gyogyszergyar Zartkoeruen Mukoedo Reszvenytarsasag Non-hygroscopic and powdery amorphous pimecrolimus
CA2615080A1 (en) * 2005-07-14 2007-01-18 Pfizer Products Inc. Process for forming amorphous azithromycin particles
RU2008120712A (ru) * 2005-12-07 2010-01-20 Вайет (Us) Способы получения кристаллического рапамицина и определения кристалличности соединений рапамицина при помощи дифференциальной сканирующей калориметрии
UA102128C2 (en) * 2008-12-05 2013-06-10 Х. Луннбек А/С Nalmefene hydrochloride dihydrate
WO2011015219A1 (en) 2009-08-06 2011-02-10 Shifa Pharmed Industrial Group Co. Process for the purification of azithromycin by separation from its thermal degradation products and/or isomers
BR112012014926A2 (pt) * 2009-12-18 2015-09-15 Univ Northwest composição compreendendo uma forma vítrea não cristalina e amorfa de azitromicina
WO2013088274A1 (en) * 2011-12-14 2013-06-20 Wockhardt Limited Anhydrous amorphous azithromycin composition free of azithromycin dihydrate
CN106188177A (zh) * 2016-07-12 2016-12-07 浙江亚太药业股份有限公司 一种阿奇霉素化合物的制备方法及其药物制剂
CN108003109A (zh) * 2017-12-18 2018-05-08 南开大学 一种大环内酯化合物的晶型及其制备方法与用途

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI8110592A8 (en) * 1981-03-06 1996-06-30 Pliva Pharm & Chem Works Process for preparing of n-methyl-11-aza-10-deoxo-10-dihydroerythromycine a and derivatives thereof
US4474768A (en) 1982-07-19 1984-10-02 Pfizer Inc. N-Methyl 11-aza-10-deoxo-10-dihydro-erytromycin A, intermediates therefor
RO107257B1 (ro) 1987-07-09 1993-10-30 Pfizer Procedeu de obtinere a unui dihidrat de azitromicina, cristalin
ES2104386T3 (es) * 1993-05-19 1997-10-01 Pfizer Compuesto intermedio para la acitromicina.
ECSP951389A (es) 1995-02-21 1996-05-10 Un procedimiento de obtencion de hidrato de azitromicina
ES2122905B1 (es) * 1996-07-11 1999-11-16 Astur Pharma Sa Sintesis de 11,12-hidrogenoortoborato de 9-desoxo-9a-aza-11,12-desoxi-9a-metil-9a-homoeritromicina a. un procedimiento para la preparacion de 9-desoxo-9a-aza-9a-metil-9a-homoeritromicina a dihidrato (azitromicina dihidrato).
PT102130A (pt) 1998-03-13 1999-09-30 Hovione Sociedade Quimica S A Processo de preparacao de dihidrato de azitromicina
TW546302B (en) * 1998-05-08 2003-08-11 Biochemie Sa Improvements in macrolide production
CA2245398C (en) * 1998-08-21 2002-01-29 Apotex Inc. Azithromycin monohydrate isopropanol clathrate and methods for the manufacture thereof

Also Published As

Publication number Publication date
ES2177373A1 (es) 2002-12-01
CA2326930A1 (en) 2001-05-26
DE60003509T2 (de) 2004-04-15
JP4260354B2 (ja) 2009-04-30
ES2177373B1 (es) 2003-11-01
DE60027919D1 (de) 2006-06-14
PL195910B1 (pl) 2007-11-30
ATE243704T1 (de) 2003-07-15
TR200003474A2 (tr) 2001-07-23
PL344101A1 (en) 2001-06-04
EP1103558A2 (de) 2001-05-30
EP1234833B1 (de) 2006-05-10
TR200003474A3 (tr) 2001-07-23
DE60003509D1 (de) 2003-07-31
CA2326930C (en) 2005-03-22
ES2207403A1 (es) 2004-05-16
EP1103558A3 (de) 2001-07-04
EP1234833A3 (de) 2003-03-12
EP1234833A2 (de) 2002-08-28
ES2207403B1 (es) 2005-03-01
JP2009007376A (ja) 2009-01-15
JP2001187797A (ja) 2001-07-10
US6451990B1 (en) 2002-09-17
EP1103558B1 (de) 2003-06-25

Similar Documents

Publication Publication Date Title
DE60027919D1 (de) Herstellung von kristalliner Dihydratform von Azithromycin
HU9400687D0 (en) Imidazolidyl macrolides
GB8823567D0 (en) 4h-1-benzopyran-4-one derivative/its salt & process for producing same
ATE119881T1 (de) 3-(2-(dimethylamino)ethyl>-n-methyl-1h-indol-5- methansulfonamid sulfat (2:1).
NZ191867A (en) N1,n1,2,3,4,5,6-substituted-1-piperazine-carboxamides and carbothioamides
NZ238340A (en) Preparation of 3-(methylamino)-piperidine derivatives
ES2193241T3 (es) Nuevas n-2-oxo2.3.4.5-tetrajodrp-1h-1,5-benzodiazepin-3-il)-3-amidas.
IL92152A (en) Process and intermediates for the preparation of 3,5-dimethyl-4- methoxypyridine derivatives
PT1122245E (pt) 2-amino-benzoxazinonas para o tratamento de infeccoes virais
KR950017992A (ko) 알프조신 염산염의 2수화물
AU6989487A (en) Phenylimidazolecarboxylic acid amides, their preparation and their use as growth regulators
DK0873346T3 (da) Ny krystallinsk form af morfin-6-glucuronid
DK0779895T3 (da) Forbedret fremgangsmåde til fremstilling af sidekædederivater af cyclohexapeptidyl-lipopeptider
CA2485433A1 (en) Preparation of non-crystalline and crystalline dihydrate forms of azithromycin
PT828749E (pt) Composicoes e metodos para a sintese de derivados de organofosforo
Amatuni et al. Diamond synthesis possibility investigation using CO {sub 2} laser radiation; Issledovanie vozmozhnosti sinteza almaza s ispolzovaniem izlucheniya CO {sub 2} lazera
Amatuni et al. Diamond synthesis possibility investigation using CO2 laser radiation
ATE100460T1 (de) Erythromycin-derivate und ihre herstellung und verwendung.
Korshunov et al. Approximation of Hartree-Fock method of atomic form factors within the framework of shell models; Approksimatsiya Khartri-Fokovskikh atomnykh form-faktorov v ramkakh obolochechnoj modeli
DE59002172D1 (de) Neue 1,3-oxazine.
Asatov et al. Diffraction of Bremsstrahlung of 22.5 MeV electrons on silicon monocrystals; Difraktsiya tormoznogo izlucheniya ehlektronov s ehnergiej 22.5 MehV na monokristalle kremniya
MAZO METHODS OF THE ATOMIC SPECTRAL ANALYSIS
ES2062062T3 (es) Procedimiento para la preparacion de eteres de la 2-amino-7-hidroxitetralina.
Shchagin et al. Simultaneous generation of several beams of parametric X radiation; Odnovremennaya generatsiya neskol'kikh puchkov parametricheskogo rentgenovskogo izlucheniya
ES2156327T3 (es) Obtencion de un epoxido.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties